Ethanol Consumption Induces Nonspecific Inflammation and Functional Defects in Alveolar Macrophages
Overview
Molecular Biology
Authors
Affiliations
Chronic alcohol drinking is associated with increased susceptibility to viral and bacterial respiratory pathogens. In this study, we use a rhesus macaque model of voluntary ethanol self-administration to study the effects of long-term alcohol drinking on the immunological landscape of the lung. We report a heightened inflammatory state in alveolar macrophages (AMs) obtained from ethanol (EtOH)-drinking animals that is accompanied by increased chromatin accessibility in intergenic regions that regulate inflammatory genes and contain binding motifs for transcription factors AP-1, IRF8, and NFKB p-65. In line with these transcriptional and epigenetic changes at the basal state, AMs from EtOH-drinking animals generate elevated inflammatory mediator responses to lipopolysaccharides and respiratory syncytial virus. However, the transcriptional analysis revealed an inefficient induction of interferon-stimulated genes with EtOH in response to the respiratory syncytial virus, suggesting disruption of antimicrobial defenses. Correspondingly, AMs from EtOH-drinking animals exhibited transcriptional shifts indicative of increased oxidative stress and oxidative phosphorylation, which was coupled with higher cytosolic reactive oxygen species and mitochondrial potential. This heightened oxidative stress state was accompanied by decreased ability to phagocytose bacteria. Bulk RNA and assay for transposase-accessible chromatin sequencing data further revealed reduced expression and chromatin accessibility of loci associated with tissue repair and maintenance with chronic EtOH drinking. Similarly, analysis of single-cell RNA sequencing data revealed shifts in cell states from tissue maintenance to inflammatory responses with EtOH. Collectively, these data provide novel insight into mechanisms by which chronic EtOH drinking increases susceptibility to infection in patients with alcohol use disorders.
Hemati H, Blanton M, True H, Koura J, Khadka R, Grant K bioRxiv. 2025; .
PMID: 39975066 PMC: 11839131. DOI: 10.1101/2025.02.05.636708.
Pommerolle L, Arif M, Behee M, Appolonia C, Basu A, Wolf K Am J Respir Cell Mol Biol. 2024; 71(5):559-576.
PMID: 39024537 PMC: 11568473. DOI: 10.1165/rcmb.2024-0086OC.
Doratt B, Malherbe D, Messaoudi I Front Immunol. 2024; 15:1408212.
PMID: 38887303 PMC: 11180879. DOI: 10.3389/fimmu.2024.1408212.
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?.
Michalak A, Lach T, Szczygiel K, Cichoz-Lach H Int J Mol Sci. 2024; 25(4).
PMID: 38396888 PMC: 10888568. DOI: 10.3390/ijms25042212.
Lewis S, Doratt B, Qiao Q, Blanton M, Grant K, Messaoudi I Stem Cell Reports. 2023; 18(9):1884-1897.
PMID: 37657446 PMC: 10545484. DOI: 10.1016/j.stemcr.2023.08.001.